Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia

被引:125
作者
Asada, J
Tsuji, H
Iwasaka, T
Thomas, JD
Lauer, MS
机构
[1] Hlth Examinat Ctr Moriguchi City, Moriguchi, Osaka 5700033, Japan
[2] Kansai Med Univ, Ctr Cardiovasc, Moriguchi, Osaka 570, Japan
[3] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
D O I
10.1016/j.amjcard.2003.11.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma brain natriuretic peptide (BNP) levels have been associated with left ventricular dysfunction and acute myocardial infarction. Although natriuretic peptide responses have been linked to exercise-induced myocardial ischemia, it is not known whether BNP levels predict dobutamine-incluced myocardial ischemia. The aim of this study was to determine whether elevations in BNP levels immediately before or after dobutamine-incluced stress are associated with echocardiographic myocardial ischemia. Plasma BNP was measured before and after stress during dobutamine-stress echocardiography in 317 patients (aged 68 +/- 11 years; 46% women) who had creatinine < 1.5 mg/dl and did not have valvular disease. Ischemia, as assessed by blinded echocardiographic interpretation, was noted in 31 patients (10%). In univariable analyses, prestress BNP was predictive of echocardiographic ischemia (rates of ischemia according to tertiles of BNP 4%, 9%, and 16%, chi-square for trend = 8, p = 0.0059). The change in BNP levels with dobutamine stress was not associated with ischemia. In multivariable analyses, after adjusting for age, gender, and left ventricular ejection fraction, BNP before and after stress remained predictive of ischemia (1 SD increase in the log of resting BNP adjusted odds ratio 2.0, 95% confidence interval 1.3 to 3.0, p = 0.002). In this pilot study, resting BNP was predictive of dobutamine-induced ischemia. Future work is needed to confirm these findings. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:702 / 704
页数:3
相关论文
共 11 条
[1]   Natriuretic peptides - Relevance in cardiovascular disease [J].
Cheung, BMY ;
Kumana, CR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (23) :1983-1984
[2]   The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Bentley, JH ;
Omland, T ;
Sabatine, MS ;
McCabe, CH ;
Hall, C ;
Cannon, CP ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021
[3]   COMPARATIVE EFFECTS OF ISCHEMIA AND HYPOXEMIA ON LEFT-VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION IN HUMANS [J].
DEBRUYNE, B ;
BRONZWAER, JGF ;
HEYNDRICKX, GR ;
PAULUS, WJ .
CIRCULATION, 1993, 88 (02) :461-471
[4]   Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction [J].
Friedl, W ;
Mair, J ;
Thomas, S ;
Pichler, M ;
Puschendorf, B .
HEART, 1996, 76 (02) :129-136
[5]  
KONO M, 1993, KAKU IGAKU, V13, P2
[6]   Utility of B-natriuretic peptide in detecting diastolic dysfunction - Comparison with Doppler velocity recordings [J].
Lubien, E ;
DeMaria, A ;
Krishnaswamy, P ;
Clopton, P ;
Koon, J ;
Kazanegra, R ;
Gardetto, N ;
Wanner, E ;
Maisel, AS .
CIRCULATION, 2002, 105 (05) :595-601
[7]   Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction [J].
Maeda, K ;
Tsutamoto, T ;
Wada, A ;
Hisanaga, T ;
Kinoshita, M .
AMERICAN HEART JOURNAL, 1998, 135 (05) :825-832
[8]   INCREASED SECRETION OF ATRIAL AND BRAIN NATRIURETIC PEPTIDES DURING ACUTE MYOCARDIAL-ISCHEMIA INDUCED BY DYNAMIC EXERCISE IN PATIENTS WITH ANGINA-PECTORIS [J].
MARUMOTO, K ;
HAMADA, M ;
HIWADA, K .
CLINICAL SCIENCE, 1995, 88 (05) :551-556
[9]   EFFECTS OF EXERCISE ON PLASMA-LEVEL OF BRAIN NATRIURETIC PEPTIDE IN CONGESTIVE-HEART-FAILURE WITH AND WITHOUT LEFT-VENTRICULAR DYSFUNCTION [J].
MATSUMOTO, A ;
HIRATA, Y ;
MOMOMURA, S ;
SUZUKI, E ;
YOKOYAMA, I ;
SATA, M ;
OHTANI, Y ;
SERIZAWA, T .
AMERICAN HEART JOURNAL, 1995, 129 (01) :139-145
[10]   Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy [J].
Nakamura, T ;
Sakamoto, K ;
Yamano, T ;
Kikkawa, M ;
Zen, K ;
Hikosaka, T ;
Kubota, T ;
Azuma, A ;
Nishimura, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (10) :1657-1663